Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide Dosing Comparison in Relapsed/Refractory Multiple Myeloma
NCT01319422Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2011
- Primary completion
- Nov 2014
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by Yale University. Started Jun 2011; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01319422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319422.